BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10115428)

  • 1. Sharps container prices hold firm due to competition.
    Barlow RD
    Hosp Mater Manage; 1991 Nov; 16(11):1, 12-3. PubMed ID: 10115428
    [No Abstract]   [Full Text] [Related]  

  • 2. Sharps container prices hold steady.
    Litsikas M
    Hosp Mater Manage; 1990 May; 15(5):1, 12-3. PubMed ID: 10104749
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppliers endure large doses of change.
    Scott L
    Mod Healthc; 1996 Oct; 26(43):36-7. PubMed ID: 10162883
    [No Abstract]   [Full Text] [Related]  

  • 4. Hip implant prices edge downward; hospitals intensify standardization push.
    Hosp Mater Manage; 1996 Sep; 21(9):1, 10-3. PubMed ID: 10160164
    [No Abstract]   [Full Text] [Related]  

  • 5. Price survey. Stent prices down, but not enough.
    Hosp Mater Manage; 1999 Apr; 24(4):1, 13-5. PubMed ID: 10351487
    [No Abstract]   [Full Text] [Related]  

  • 6. Most hospital supply prices headed upward in 1998.
    Hosp Mater Manage; 1998 Jan; 23(1):2-3. PubMed ID: 10176481
    [No Abstract]   [Full Text] [Related]  

  • 7. I.V. prices may creep upward in 1999.
    Hosp Mater Manage; 1999 Jan; 24(1):1, 13-5. PubMed ID: 10339215
    [No Abstract]   [Full Text] [Related]  

  • 8. Sharps strategy. Start with the right tools.
    Pugliese G
    Mater Manag Health Care; 1999 May; 8(5):20, 22, 24-6. PubMed ID: 10537452
    [No Abstract]   [Full Text] [Related]  

  • 9. Personal protective equipment prices, under competitive pressure, still falling.
    Hosp Mater Manage; 1996 May; 21(5):1, 12-3. PubMed ID: 10157581
    [No Abstract]   [Full Text] [Related]  

  • 10. Suture prices unlikely to drop further.
    Hosp Mater Manage; 1998 Dec; 23(12):1, 14-5. PubMed ID: 10338811
    [No Abstract]   [Full Text] [Related]  

  • 11. July indexes send mixed signals: consumer prices up 0.4%, producer prices up 0.5%.
    Hosp Mater Manage; 1988 Sep; 13(9):13. PubMed ID: 10289921
    [No Abstract]   [Full Text] [Related]  

  • 12. Consider usage, not just supply prices.
    Hosp Mater Manage; 1987 Jun; 12(6):12-5. PubMed ID: 10283109
    [No Abstract]   [Full Text] [Related]  

  • 13. Med-surg prices steady at 160.6, while brand-name drug prices decrease slightly.
    Hosp Mater Manage; 1988 Apr; 13(4):12-5. PubMed ID: 10318063
    [No Abstract]   [Full Text] [Related]  

  • 14. Hospital supply and pharmaceutical costs are tied to competition in marketplace.
    Appel GL
    Hosp Mater Manage; 1995 Dec; 20(12):8-9. PubMed ID: 10152660
    [No Abstract]   [Full Text] [Related]  

  • 15. Needle and syringe prices decline.
    Hosp Mater Manage; 1989 Oct; 14(10):1, 12-4. PubMed ID: 10295565
    [No Abstract]   [Full Text] [Related]  

  • 16. Supply prices expected to hold steady.
    Hosp Mater Manage; 1999 Mar; 24(3):10-1. PubMed ID: 10346627
    [No Abstract]   [Full Text] [Related]  

  • 17. Food and nutrition services non-salary expenses.
    Veasey N
    Hosp Mater Manage; 1992 Nov; 17(11):8-9. PubMed ID: 10122379
    [No Abstract]   [Full Text] [Related]  

  • 18. Competition closing gap between I.V. prices groups pay.
    Kuntz EF
    Mod Healthc; 1983 Sep; 13(9):78-80. PubMed ID: 10262459
    [No Abstract]   [Full Text] [Related]  

  • 19. Purchasing execs look to future with optimism.
    Hosp Mater Manage; 1998 Jul; 23(7):11. PubMed ID: 10183020
    [No Abstract]   [Full Text] [Related]  

  • 20. Price survey: X-ray film. Tough competition tempers prices.
    Werner C
    Hosp Mater Manage; 1992 Dec; 17(12):1, 14-5. PubMed ID: 10123290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.